期刊文献+

垂体瘤显微手术后尿崩的预防和治疗 被引量:3

The prevention and treatment of diabetes insipidus after excision of pituitary adenoma by microsurgery
下载PDF
导出
摘要 目的探讨垂体腺瘤术后尿崩症的预防和治疗,以减少术后尿崩的发生,提高垂体腺瘤手术的疗效。方法回顾总结2012年8月至2015年8月本院神经外科显微手术治疗垂体腺瘤患者84例,26例肿瘤直径〉3cm向鞍上、鞍旁生长的巨大垂体腺瘤采用经额下入路显微手术摘除肿瘤,其余58例行单鼻孔蝶窦入路切除肿瘤,统计尿崩症的预防、发生和治疗情况。结果84例患者术后出现尿崩35例f41.7%),其中26例巨大垂体腺瘤病例中发生尿崩19例(73.0%),其余58例垂体腺瘤病例术后发生尿崩16例(27.6%)。经对症治疗,尿崩持续时间〈3周的21例,持续3周~3个月的12例,发生永久性尿崩的2例。结论术前全面检查、充分准备,熟悉垂体后叶亮点的位置及肿瘤与周边组织的三维立体关系,术中避免损伤垂体、垂体柄、下丘脑及其供血血管,术后及时合理使用抗利尿药物与纠正水电解质平衡紊乱是预防和治疗垂体腺瘤术后尿崩症的关键。 Objective To explore the prevention and treatment of postoperative diabetes insipidus after excision of pituitary adenoma by mierosurgery, to decrease the incidence of postoperative complications, and improve the treatment effect of pituitary adenoma. Methods 84 cases of pituitary adenomas undergoing mierosurgical resection in our hospital from August 2012 to August 2015 were retrospectively reviewed. 26 cases of giant pituitary adenoma (precise tumor diameter 〉3 cm, extending into suprasellar and parasellar region) were excised through unilateral subfrontal approach, and other 58 cases of pituitary tumor were removed by transsphenoidal operation. The incidence, prevention, and treatment of diabetes insipidus were statistically analyzed. Results 35 cases (41.7%) had postoperative diabetes insipidns among the total 84 operations, 19 of them occurred in 26 cases of giant pituitary adenoma (73.0%), the rest 16 cases occurred in 58 cases of pituitary adenoma (27.6%). By symptomatic treatment, 21 patients recovered within 3 weeks, 12 patients recovered within 3 weeks to 3 months, another 2 patients didn't recover. Conclusions Pre-operation sufficient preparation, familiarizing the position of posterior pituitary bright spot (PPBS) and three dimensional relationship of the tumor and the surrounding tissue; intra-operation avoiding injury of pituitary gland, pituitary stalk, hypothalamus, and supplying vessels; post-operation rational anti-diuretics using and correcting electrolyte balance, are key points to prevent and treat postoperative diabetes insipidus.
出处 《国际医药卫生导报》 2016年第21期3243-3244,3247,共3页 International Medicine and Health Guidance News
关键词 尿崩症 垂体腺瘤 显微手术 Diabetes insipidus Pituitary adenoma Microsurgery
  • 相关文献

参考文献7

  • 1Gigineishvili D, Gigineishvili T, Tsiskaridze A, et al. Incidence rates of the primary brain tumours in Georgia--a population-based study[J].BMC Neurol, 2014, 14:29. DOI: 10.1186/1471-2377-14-29.
  • 2Nemergut EC, Zuo Z, Jane JA Jr, et al. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients[J].J Neurosurg, 2005, 103(3):448-454.
  • 3林昆哲,王守森.神经垂体的功能状态评估[J].中华神经医学杂志,2014,13(8):854-857. 被引量:5
  • 4Saeki N, Hayasaka M, Murai H, et al. Posterior pituitary bright spot in large adenomas: MR assessment of its disappearance or relocation along the stalk[J].Radiology, 2003, 226(2):359-365.
  • 5Kilday JP, Laughlin S, Urbach S, et al. Diabetes insipidus in pediatric germinomas of the suprasellar region: characteristic features and significance of the pituitary bright spot[J].J Neurooncol, 2015, 121(1):167- 175. DOI: 10. lO07/s11060-014-1619-7.
  • 6Lucas JW, Zada G. Imaging of the pituitary and parasellar region[J].Semin Neurol, 2012, 32(4):320-331. DOI: 10.1055/s-0032-1331806.
  • 7Bonneville F, Narboux Y, Cattin F, et al. Preoperative location of the pituitary bright spot in patients with pituitary macroadenomas[J].AJNR Am J Neuroradiol, 2002, 23(4):528-532.

二级参考文献32

  • 1Schreckinger M,Szerlip N,Mittal S.Diabetes insipidus following resection of pituitary tumors[J].Clin Neurol Neurosurg,2013,115(2):121-126.
  • 2Fenske W,Allolio B.Clinical review:Current state and future perspectives in the diagnosis of diabetes insipidus:a clinical review[J].J Clin Endocrinol Metab,2012,97(10):3426-3437.
  • 3Calabro RS,Italiano D,Ferrara D,et al.The hypothalamic-neurohypophyseal system:current and future treatment of vasopressin and oxytocyn related disorders[J].Recent Pat Endocr Metab Immune Drug Discov,2012,6(3):235-250.
  • 4Holt NF,Haspel KL.Vasopressin:a review of therapeutic applications[J].J Cardiothorac Vasc Anesth,2010,24(2):330-347.
  • 5Vincent JL,Su F.Physiology and pathophysiology of the vasopressinergic system[J].Best Pract Res Clin Anaesthesiol,2008,22(2):243-252.
  • 6Morgenthaler NG,Struck J,Jochberger S,et al.Copeptin:clinical use of a new biomarker[J].Trends Endocrinol Metab,2008,19(2):43-49.
  • 7Bellastella A,Bizzarro A,Colella C,et al.Subclinical diabetes insipidus[J].Best Pract Res Clin Endocrinol Metab,2012,26(4):471-483.
  • 8Pratheesh R,Swallow DM,Rajaratnam S,et al.Incidence,predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma:a comparison with adults[J].Childs Nerv Syst,2013,29(6):941-949.
  • 9Devin JK.Hypopituitarism and central diabetes insipidus:perioperative diagnosis and management[J].Neurosurg Clin N Am,2012,23(4):679-689.
  • 10Fenske W,Quinkler M,Lorenz D,et al.Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome-revisiting the direct and indirect water deprivation tests[J].J Clin Endocrinol Metab,2011,96(5):1506-1515.

共引文献4

同被引文献21

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部